Puma Biotechnology Inc (NASDAQ: PBYI) stock closed at $3.44 on 7/11/24 after a major increase of 13.2%. NORMAL trading volume accompanied the advance. The stock has risen 11.0% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, PBYI is expected to continue to be a major Value Builder.
Puma Biotechnology has a current Value Trend Rating of C (High Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Puma Biotechnology has a neutral Appreciation Score of 52 and a slightly positive Power Rating of 63, producing the High Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment